These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8615863)
1. Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4. Gelboin HV; Krausz KW; Goldfarb I; Buters JT; Yang SK; Gonzalez FJ; Korzekwa KR; Shou M Biochem Pharmacol; 1995 Nov; 50(11):1841-50. PubMed ID: 8615863 [TBL] [Abstract][Full Text] [Related]
2. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver. Sai Y; Yang TJ; Krausz KW; Gonzalez FJ; Gelboin HV Pharmacogenetics; 1999 Apr; 9(2):229-37. PubMed ID: 10376770 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory monoclonal antibody to human cytochrome P450 2B6. Yang TJ; Krausz KW; Shou M; Yang SK; Buters JT; Gonzalez FJ; Gelboin HV Biochem Pharmacol; 1998 May; 55(10):1633-40. PubMed ID: 9633999 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies specific and inhibitory to human cytochromes P450 2C8, 2C9, and 2C19. Krausz KW; Goldfarb I; Buters JT; Yang TJ; Gonzalez FJ; Gelboin HV Drug Metab Dispos; 2001 Nov; 29(11):1410-23. PubMed ID: 11602516 [TBL] [Abstract][Full Text] [Related]
5. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism. Mei Q; Tang C; Assang C; Lin Y; Slaughter D; Rodrigues AD; Baillie TA; Rushmore TH; Shou M J Pharmacol Exp Ther; 1999 Nov; 291(2):749-59. PubMed ID: 10525096 [TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody inhibitory to human P450 2D6: a paradigm for use in combinatorial determination of individual P450 role in specific drug tissue metabolism. Gelboin HV; Krausz KW; Shou M; Gonzalez FJ; Yang TJ Pharmacogenetics; 1997 Dec; 7(6):469-77. PubMed ID: 9429232 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory monoclonal antibodies to human cytochrome P450 1A2: analysis of phenacetin O-deethylation in human liver. Yang TJ; Sai Y; Krausz KW; Gonzalez FJ; Gelboin HV Pharmacogenetics; 1998 Oct; 8(5):375-82. PubMed ID: 9825829 [TBL] [Abstract][Full Text] [Related]
8. Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver. Shou M; Martinet M; Korzekwa KR; Krausz KW; Gonzalez FJ; Gelboin HV Pharmacogenetics; 1998 Oct; 8(5):391-401. PubMed ID: 9825831 [TBL] [Abstract][Full Text] [Related]
9. Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism. Yang TJ; Krausz KW; Sai Y; Gonzalez FJ; Gelboin HV Drug Metab Dispos; 1999 Jan; 27(1):102-9. PubMed ID: 9884317 [TBL] [Abstract][Full Text] [Related]
10. Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib. Uttamsingh V; Lu C; Miwa G; Gan LS Drug Metab Dispos; 2005 Nov; 33(11):1723-8. PubMed ID: 16103134 [TBL] [Abstract][Full Text] [Related]
11. Midazolam is metabolized by at least three different cytochrome P450 enzymes. Wandel C; Böcker R; Böhrer H; Browne A; Rügheimer E; Martin E Br J Anaesth; 1994 Nov; 73(5):658-61. PubMed ID: 7826796 [TBL] [Abstract][Full Text] [Related]
12. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone. Shou M; Korzekwa KR; Brooks EN; Krausz KW; Gonzalez FJ; Gelboin HV Carcinogenesis; 1997 Jan; 18(1):207-14. PubMed ID: 9054608 [TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Patten CJ; Thomas PE; Guy RL; Lee M; Gonzalez FJ; Guengerich FP; Yang CS Chem Res Toxicol; 1993; 6(4):511-8. PubMed ID: 8374050 [TBL] [Abstract][Full Text] [Related]
14. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4. Relling MV; Nemec J; Schuetz EG; Schuetz JD; Gonzalez FJ; Korzekwa KR Mol Pharmacol; 1994 Feb; 45(2):352-8. PubMed ID: 8114683 [TBL] [Abstract][Full Text] [Related]
15. An inhibitory monoclonal antibody to human cytochrome P450 that specifically binds and inhibits P4502C9II, an allelic variant of P4502C9 having a single amino acid change Arg144 Cys. Krausz KW; Goldfarb I; Yang TJ; Gonzalez FJ; Gelboin HV Xenobiotica; 2000 Jun; 30(6):619-25. PubMed ID: 10923863 [TBL] [Abstract][Full Text] [Related]
16. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin. Heyn H; White RB; Stevens JC Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603 [TBL] [Abstract][Full Text] [Related]
17. Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily. Ono S; Hatanaka T; Miyazawa S; Tsutsui M; Aoyama T; Gonzalez FJ; Satoh T Xenobiotica; 1996 Nov; 26(11):1155-66. PubMed ID: 8948091 [TBL] [Abstract][Full Text] [Related]
18. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4. Spracklin DK; Thummel KE; Kharasch ED Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory and noninhibitory monoclonal antibodies to human cytochrome P450 2E1. Gelboin HV; Goldfarb I; Krausz KW; Grogan J; Korzekwa KR; Gonzalez FJ; Shou M Chem Res Toxicol; 1996 Sep; 9(6):1023-30. PubMed ID: 8870991 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Chang TK; Gonzalez FJ; Waxman DJ Arch Biochem Biophys; 1994 Jun; 311(2):437-42. PubMed ID: 8203907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]